Skip to main content

Advertisement

Log in

Prevalence of cortical superficial siderosis in patients with cognitive impairment

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Cortical superficial siderosis (cSS) is a magnetic resonance imaging marker of cerebral amyloid angiopathy (CAA) and can be its sole imaging sign. cSS has further been identified as a risk marker for future intracranial hemorrhage. Although uncommon in the general population, cSS may be much more prevalent in high risk populations for amyloid pathology. We aimed to determine the frequency of cSS in patients with cognitive impairment presenting to a memory clinic. We prospectively evaluated consecutive patients presenting to our memory clinic between April 2011 and April 2013. Subjects received neuropsychological testing using the Consortium to Establish a Registry for Alzheimer’s Disease battery (CERAD-NP). Two hundred and twelve patients with documented cognitive impairment further underwent a standardized 3T-MR-imaging protocol with T2*-weighted gradient-echo sequences for detection of cSS. Thirteen of 212 patients (6.1 %) displayed cSS. In seven of them (54 %) cSS was the only imaging sign of CAA. Patients with cSS did not differ from patients without cSS with regard to medical history, age or cardiovascular risk profile. Subjects with cSS performed worse in the mini-mental state examination (p = 0.001), showed more white matter hyperintensities (p = 0.005) and more often had microbleeds (p = 0.001) compared to those without cSS. cSS is common in patients with cognitive impairment. It is associated with lower cognitive scores, white matter hyperintensities and microbleeds and can be the only imaging sign for CAA in this patient group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Knudsen KA, Rosand J, Karluk D, Greenberg SM (2001) Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology 56:537–539. doi:10.1212/WNL.56.4.537

    Article  CAS  PubMed  Google Scholar 

  2. Linn J, Bruckmann H (2010) Superficial siderosis in cerebral amyloid angiopathy. AJNR Am J Neuroradiol 31:E29. doi:10.3174/ajnr.A1913

    Article  CAS  PubMed  Google Scholar 

  3. Charidimou A, Jager RH, Fox Z, Peeters A, Vandermeeren Y, Laloux P, Baron JC, Werring DJ (2013) Prevalence and mechanisms of cortical superficial siderosis in cerebral amyloid angiopathy. Neurology 81:626–632. doi:10.1212/WNL.0b013e3182a08f2c

    Article  PubMed  Google Scholar 

  4. Linn J, Halpin A, Demaerel P, Ruhland J, Giese AD, Dichgans M, van Buchem MA, Bruckmann H, Greenberg SM (2010) Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology 74:1346–1350. doi:10.1212/WNL.0b013e3181dad605

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Vernooij MW, Ikram MA, Hofman A, Krestin GP, Breteler MM, van der Lugt A (2009) Superficial siderosis in the general population. Neurology 73:202–205. doi:10.1212/WNL.0b013e3181ae7c5e

    Article  CAS  PubMed  Google Scholar 

  6. Linn J, Wollenweber FA, Lummel N, Bochmann K, Pfefferkorn T, Gschwendtner A, Bruckmann H, Dichgans M, Opherk C (2013) Superficial siderosis is a warning sign for future intracranial hemorrhage. J Neurol 260:176–181. doi:10.1007/s00415-012-6610-7

    Article  PubMed  Google Scholar 

  7. Petersen RC (2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256:183–194. doi:10.1111/j.1365-2796.2004.01388.x

    Article  CAS  PubMed  Google Scholar 

  8. Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198. doi:10.1016/0022-3956(75)90026-6

    Article  CAS  PubMed  Google Scholar 

  9. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C (1989) The consortium to establish a registry for Alzheimer’s disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology 39:1159–1165. doi:10.1212/WNL.39.9.1159

    Article  CAS  PubMed  Google Scholar 

  10. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO (1982) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17:37–49. doi:10.1016/0022-3956(82)90033-4

    Article  PubMed  Google Scholar 

  11. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O’Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, Decarli C, de Leeuw FE, Doubal F, Duering M, Fox NC, Greenberg S, Hachinski V, Kilimann I, Mok V, Oostenbrugge R, Pantoni L, Speck O, Stephan BC, Teipel S, Viswanathan A, Werring D, Chen C, Smith C, van Buchem M, Norrving B, Gorelick PB, Dichgans M, nEuroimaging STfRVco (2013) Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lan Neurol 12:822–838. doi:10.1016/S1474-4422(13)70124-8

    Article  Google Scholar 

  12. Wahlund LO, Agartz I, Almqvist O, Basun H, Forssell L, Saaf J, Wetterberg L (1990) The brain in healthy aged individuals: MR imaging. Radiology 174:675–679. doi:10.1148/radiology.174.3.2305048

    Article  CAS  PubMed  Google Scholar 

  13. Charidimou A, Gang Q, Werring DJ (2012) Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatr 83:124–137. doi:10.1136/jnnp-2011-301308

    Article  PubMed  Google Scholar 

  14. Ellis RJ, Olichney JM, Thal LJ, Mirra SS, Morris JC, Beekly D, Heyman A (1996) Cerebral amyloid angiopathy in the brains of patients with Alzheimer’s disease: the CERAD experience, part XV. Neurology 46:1592–1596. doi:10.1212/WNL.46.6.1592

    Article  CAS  PubMed  Google Scholar 

  15. Arvanitakis Z, Leurgans SE, Wang Z, Wilson RS, Bennett DA, Schneider JA (2011) Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol 69:320–327. doi:10.1002/ana.22112

    Article  PubMed Central  PubMed  Google Scholar 

  16. O’Donnell HC, Rosand J, Knudsen KA, Furie KL, Segal AZ, Chiu RI, Ikeda D, Greenberg SM (2000) Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. New Engl J Med 342:240–245. doi:10.1056/NEJM200001273420403

    Article  PubMed  Google Scholar 

  17. Rosand J, Hylek EM, O’Donnell HC, Greenberg SM (2000) Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology 55:947–951. doi:10.1212/WNL.55.7.947

    Article  CAS  PubMed  Google Scholar 

Download references

Conflicts of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Frank Arne Wollenweber.

Additional information

J. Linn and C. Opherk contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wollenweber, F.A., Buerger, K., Mueller, C. et al. Prevalence of cortical superficial siderosis in patients with cognitive impairment. J Neurol 261, 277–282 (2014). https://doi.org/10.1007/s00415-013-7181-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-013-7181-y

Keywords

Navigation